Paget's disease of bone
Background
- Characterized by areas of bone with excessive osteolytic activity and subsequent increased ostoblastic activity, resulting in disorganized bone formation
- Results in osteolytic lesions and weakened bone
- Eventually, affected bones may be abnormally enlarged
- Exact etiology unknown, likely genetic component
- Prevalence increases with age, more common in people of European descent
Clinical Features
- Initially asymptomatic or mild pain
- Bone pain at affected sites, often worse at night
- Pathologic fractures
- If skull involved, may report increased hat size, headache, decreased hearing
Differential Diagnosis
- Bone tumor (e.g. osteosarcoma or metastesis)
- Multiple myeloma, myelofibrosis
- Fibrous dysplasia
- Intramedullary osteosclerosis
- Sickle cell disease
Bone tumors and their mimics
Malignant
- Multiple myeloma
- Chondrosarcoma
- Paget disease
- Osteosarcoma
- Adamantinoma
- Chordoma
- Primary bone lymphoma
- Fibrosarcoma
- Myosarcoma
Benign
- Giant cell tumor
- Chrondroblastoma
- Enchondroma
- Langerhans cell histiocytosis of bone
- Osteoblastoma
- Osteochondroma
- Osteoid osteoma
Other
Evaluation
- Imaging to evaluate for fractures
- Initial lesion may be destructive, radiolucent (especially in skull)
- Involved bones may be expanded, abnormally dense
- May have multiple fissure fractures in long bones
- Alk phos typically very high
- Serum calcium may be high
Management
- Treat fractures
- Pain control
- Bisphosphonates (e.g. Zoledronate) are treatment of choice for patients with severe symptoms or advanced disease
Disposition
- Discharge uncomplicated patients